Literature DB >> 22408707

Bullous pemphigoid triggered by swine flu vaccination: case report and review of vaccine triggered pemphigoid.

Natasha Walmsley1, Philip Hampton.   

Abstract

BACKGROUND: Bullous pemphigoid (BP) is an acquired autoimmune blistering disease mainly affecting the elderly. Recent reports have shown an association with pre-existing neurodegenerative diseases. Triggers including diseases, medications and vaccination have been reported although in most patients no clear trigger is identified. MAIN OBSERVATIONS: We report a case of atypical bullous pemphigoid which was strongly suspected to have been triggered by the swine flu vaccination. This is the first reported case of pemphigoid triggered by this vaccine.
CONCLUSIONS: The use of the swine flu vaccine is likely to increase in the future and it is important that clinicians are aware of the potential adverse effect of swine flu vaccination induced bullous pemphigoid.

Entities:  

Keywords:  adverse effect; flu; injection site; pemphigoid; vaccine

Year:  2011        PMID: 22408707      PMCID: PMC3241950          DOI: 10.3315/jdcr.2011.1081

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  14 in total

1.  Bullous pemphigoid in infancy developing after the first vaccination.

Authors:  J Hafiji; B Bhogal; E Rytina; N P Burrows
Journal:  Clin Exp Dermatol       Date:  2010-12       Impact factor: 3.470

Review 2.  What's new in bullous pemphigoid.

Authors:  Hideyuki Ujiie; Akihiko Shibaki; Wataru Nishie; Hiroshi Shimizu
Journal:  J Dermatol       Date:  2010-03       Impact factor: 4.005

3.  A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases.

Authors:  Giuseppe Stinco; Rolando Codutti; Marco Scarbolo; Francesca Valent; Pasquale Patrone
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

Review 4.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen.

Authors:  V A Venning; P H Whitehead; I M Leigh; J Allen; F Wojnarowska
Journal:  Br J Dermatol       Date:  1991-12       Impact factor: 9.302

Review 6.  Drug-induced pemphigoid: bullous and cicatricial.

Authors:  S Vassileva
Journal:  Clin Dermatol       Date:  1998 May-Jun       Impact factor: 3.541

7.  Bullous pemphigoid induced by vaccination.

Authors:  B Fournier; V Descamps; F Bouscarat; B Crickx; S Belaich
Journal:  Br J Dermatol       Date:  1996-07       Impact factor: 9.302

8.  Does influenza vaccination induce bullous pemphigoid? A report of four cases.

Authors:  A M Downs; J T Lear; C P Bower; C T Kennedy
Journal:  Br J Dermatol       Date:  1998-02       Impact factor: 9.302

9.  Bullous pemphigoid following influenza vaccination.

Authors:  J T Lear; B B Tan; J S English
Journal:  Clin Exp Dermatol       Date:  1996-09       Impact factor: 3.470

Review 10.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

View more
  8 in total

1.  Covid-19 dermatoses: Acral vesicular pattern evolving into bullous pemphigoid.

Authors:  P K C Goon; O Bello; L A Adamczyk; J Y H Chan; H Sudhoff; C C Banfield
Journal:  Skin Health Dis       Date:  2020-11-11

2.  Bullous pemphigoid and COVID-19 vaccine.

Authors:  Israel Pérez-López; David Moyano-Bueno; Ricardo Ruiz-Villaverde
Journal:  Med Clin (Barc)       Date:  2021-05-27       Impact factor: 1.725

3.  A Systematic Review of Drug-Induced Pemphigoid.

Authors:  Matthew J Verheyden; Asli Bilgic; Dédée F Murrell
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

4.  Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.

Authors:  Fouad Alshammari; Yacoub Abuzied; Abdulrahman Korairi; Mohammed Alajlan; Mohammed Alzomia; Mohammed AlSheef
Journal:  Ann Med Surg (Lond)       Date:  2022-03-01

5.  Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

Authors:  Carlo Alberto Maronese; Marzia Caproni; Chiara Moltrasio; Giovanni Genovese; Pamela Vezzoli; Paolo Sena; Giulia Previtali; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi; Laura Atzori; Emiliano Antiga; Roberto Maglie; Francesco Moro; Elena Biancamaria Mariotti; Alberto Corrà; Sabatino Pallotta; Biagio Didona; Angelo Valerio Marzano; Giovanni Di Zenzo
Journal:  Front Med (Lausanne)       Date:  2022-02-28

6.  Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination.

Authors:  Mohammed Shanshal
Journal:  Cureus       Date:  2022-06-28

7.  May Bacterial Infections Trigger Bullous Pemphigoid? Case Report and Review of Literature.

Authors:  Michela Ileen Biondo; Chiara Fiorentino; Severino Persechino; Antonella Tammaro; Angela Koverech; Armando Bartolazzi; Salvatore Raffa; Marco Canzoni; Andrea Picchianti-Diamanti; Roberta Di Rosa; Giovanni Di Zenzo; Enrico Scala; Giorgia Meneguzzi; Claudia Ferlito; Milica Markovic; Sara Caporuscio; Maria Laura Sorgi; Simonetta Salemi; Bruno Laganà
Journal:  Microorganisms       Date:  2021-06-07

Review 8.  Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature.

Authors:  P Coto-Segura; M Fernández-Prada; M Mir-Bonafé; B García-García; I González-Iglesias; P Alonso-Penanes; M González-Guerrero; A Gutiérrez-Palacios; E Miranda-Martínez; F Martinón-Torres
Journal:  Clin Exp Dermatol       Date:  2021-09-02       Impact factor: 4.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.